Log In
Print
BCIQ
Print
Print this Print this
 

AV-101 (4-CI-KYN, L-4-chlorokynurenine)

  Manage Alerts
Collapse Summary General Information
Company VistaGen Therapeutics Inc.
DescriptionNMDA receptor antagonist
Molecular Target NMDA receptor
Mechanism of ActionNMDA receptor antagonist
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today